Involuntary Memories Investigation in Schizophrenia

Schizophrenia Clinical Trial

Official title:

Involuntary Memories Investigation in Schizophrenia

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT03209778
• Other study ID #: 6620
• Status: Terminated
• Phase: N/A
• Start date: September 29, 2017
• Est. completion date: December 15, 2019

Study information

• Verified date: September 2021
• Source: University Hospital, Strasbourg, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Patients with schizophrenia suffer from autobiographical memory disorders. Patients have difficulty to remember vividly personal past events when they are specifically asked for. Indeed, this task requires a good executive functioning to retrieve precise information stored in long term memory. Interestingly, executive functioning has been showed impaired in schizophrenia and studies showed that their autobiographical memory impairments were directed related to their executive dysfunction.

Yet, in daily life people remember more often autobiographical memories spontaneously, without trying voluntarily to recall them.

In that case, the involuntary recall of personal past events is much less sustained by executive functioning.

In this protocol the investigators would like to investigate and compare subjective characteristics of involuntary and voluntary autobiographical memories in order to highlight the role of executive dysfunction in patients' autobiographical memory impairments.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 65
• Est. completion date: December 15, 2019
• Est. primary completion date: December 15, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 55 Years

Eligibility

Inclusion Criteria:

• - for patients only

• male or female

• age limits : 18-55 years old

• under the protection of health insurance

• who have signed up the consent form

• schizophrenia or schizo-affective disorder according to the DSM-5 criteria (APA, 2013).

• clinically stable for at least 2 months

• patients under guardianship or curatorship need agreement of their legal representative

• informed of the results of prior medical examination for controls only

• male or female

• age limits : 18-55 years old

• under the protection of health insurance

• who have sign up the consent form

• recruited from the general population and matched on gender, age years of schooling

• no psychiatric history (DSM-5)

Exclusion Criteria:

• for both patients and controls

• current severe or unstable somatic illness

• neurological history (brain injury > 15 minutes loss of consciousness , epilepsia, brain surgery…)

• current substance use disorder (DSM-5)

• current major depressive disorder (CDSS,BDI, HDRS)

• mental retardation (IQ < 70, WAIS-4, f-NART)

• history of general anesthesia 3 months prior to the experiment

• pregnancy declared by the subject

• breast feeding

• current legal control

• in emergency situation

• included during exclusion period in another experiment

• for controls only

• taking of antipsychotic drugs for the 3 weeks prior to inclusion

• under guardianship or curatorship

Related Conditions & MeSH terms

• Schizophrenia

Intervention

Other:
• Patients with Schizophrenia
Patients with schizophrenia or schizoaffective disorder according to DSM-V criteria

Locations

Country	Name	City	State
France	Les Hôpitaux Universitaires	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Autobiographical subjective score taking into account memories vividness and specifity		8 months